BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15372070)

  • 1. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice.
    Tuite A; Elias M; Picard S; Mullick A; Gros P
    Genes Immun; 2005 Dec; 6(8):672-82. PubMed ID: 16079897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to Candida albicans: Th1, Th2 cells and beyond.
    Romani L
    Curr Opin Microbiol; 1999 Aug; 2(4):363-7. PubMed ID: 10458979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of resistance to infection with Candida albicans in mice.
    Marquis G; Montplaisir S; Pelletier M; Auger P; Lapp WS
    Br J Exp Pathol; 1988 Oct; 69(5):651-60. PubMed ID: 3058198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate and adaptive immunity in Candida albicans infections and saprophytism.
    Romani L
    J Leukoc Biol; 2000 Aug; 68(2):175-9. PubMed ID: 10947060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility.
    Fulurija A; Ashman RB; Papadimitriou JM
    J Med Vet Mycol; 1997; 35(3):197-203. PubMed ID: 9229336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to fungal infections.
    Blanco JL; Garcia ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):47-70. PubMed ID: 18565595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans.
    Ito S; Pedras-Vasconcelos J; Klinman DM
    Infect Immun; 2005 Sep; 73(9):6154-6. PubMed ID: 16113339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
    Held K; Thiel S; Loos M; Petry F
    Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
    Dimitrova P; Yordanov M; Danova S; Ivanovska N
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
    Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
    Villamón E; Gozalbo D; Roig P; Murciano C; O'Connor JE; Fradelizi D; Gil ML
    Eur Cytokine Netw; 2004; 15(3):263-71. PubMed ID: 15542452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in the mechanisms of host resistance to Candida albicans infection?
    Ashman RB; Papadimitriou JM
    Pathol Res Pract; 1990 Aug; 186(4):527-34. PubMed ID: 2247381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated model of the recognition of Candida albicans by the innate immune system.
    Netea MG; Brown GD; Kullberg BJ; Gow NA
    Nat Rev Microbiol; 2008 Jan; 6(1):67-78. PubMed ID: 18079743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility of two species of macaques to experimental vaginal candidiasis.
    Steele C; Ratterree M; Fidel PL
    J Infect Dis; 1999 Sep; 180(3):802-10. PubMed ID: 10438369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection.
    Zafirova Y; Yordanov M; Kalfin R
    Int Immunol; 2004 Aug; 16(8):1125-31. PubMed ID: 15237107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.